403 related articles for article (PubMed ID: 17456640)
1. Glucocorticosteroid-induced osteoporosis in adult primiparous Göttingen miniature pigs: effects on bone mineral and mineral metabolism.
Scholz-Ahrens KE; Delling G; Stampa B; Helfenstein A; Hahne HJ; Açil Y; Timm W; Barkmann R; Hassenpflug J; Schrezenmeir J; Glüer CC
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E385-95. PubMed ID: 17456640
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of genistein aglycone on the development of osteonecrosis of the femoral head and secondary osteoporosis induced by methylprednisolone in rats.
Bitto A; Polito F; Burnett B; Levy R; Di Stefano V; Armbruster MA; Marini H; Minutoli L; Altavilla D; Squadrito F
J Endocrinol; 2009 Jun; 201(3):321-8. PubMed ID: 19332450
[TBL] [Abstract][Full Text] [Related]
3. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
Brzóska MM; Moniuszko-Jakoniuk J
Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044
[TBL] [Abstract][Full Text] [Related]
4. Effects of stanozolol on bone mineral density and bone biomechanical properties of osteoporotic rats.
Liao JM; Wu T; Li QN; Hu B; Huang LF; Li ZH; Yuan L; Zhong SZ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1117-20. PubMed ID: 14625163
[TBL] [Abstract][Full Text] [Related]
5. Ibandronate treatment reverses glucocorticoid-induced loss of bone mineral density and strength in minipigs.
Glüer CC; Scholz-Ahrens KE; Helfenstein A; Delling G; Timm W; Açil Y; Barkmann R; Hassenpflug J; Stampa B; Bauss F; Schrezenmeir J
Bone; 2007 Mar; 40(3):645-55. PubMed ID: 17174621
[TBL] [Abstract][Full Text] [Related]
6. [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].
Wang QH; Wu HX; Huang YL; Xue J; Yang XY; Zhu L; Wen LH
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1888-91. PubMed ID: 19040000
[TBL] [Abstract][Full Text] [Related]
7. The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
Boivin G; Meunier PJ
Osteoporos Int; 2003; 14 Suppl 3():S19-24. PubMed ID: 12730799
[TBL] [Abstract][Full Text] [Related]
8. [Effects of Xianling Gubao capsules for the treatment of bone loss induced by glucocorticoid].
Wu JJ; Wen LP; Wu YG; Shen Q; Han Y
Zhongguo Gu Shang; 2009 Mar; 22(3):193-5. PubMed ID: 19366101
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
De Nijs RN
Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of copper supplementation on deposition of fluoride in bone in fluoride- and molybdenum-fed rabbits.
Khandare AL; Suresh P; Kumar PU; Lakshmaiah N; Manjula N; Rao GS
Calcif Tissue Int; 2005 Oct; 77(4):233-8. PubMed ID: 16193231
[TBL] [Abstract][Full Text] [Related]
11. [Glucocorticoids and osteoporosis].
Zikán V
Vnitr Lek; 2007; 53(7-8):831-40. PubMed ID: 17915428
[TBL] [Abstract][Full Text] [Related]
12. The effect of long-term glucocorticoids on bone metabolism in systemic lupus erythematosus patients: the prevalence of its anti-inflammatory action upon bone resorption.
Korczowska I; Olewicz-Gawlik A; Hrycaj P; Lacki J
Yale J Biol Med; 2003; 76(2):45-54. PubMed ID: 15369631
[TBL] [Abstract][Full Text] [Related]
13. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.
Oxlund H; Ortoft G; Thomsen JS; Danielsen CC; Ejersted C; Andreassen TT
Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210
[TBL] [Abstract][Full Text] [Related]
14. Randomized withdrawal of long-term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral density.
Tengstrand B; Larsson E; Klareskog L; Hafström I
Scand J Rheumatol; 2007; 36(5):351-8. PubMed ID: 17963164
[TBL] [Abstract][Full Text] [Related]
15. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.
Mori H; Tanaka M; Kayasuga R; Masuda T; Ochi Y; Yamada H; Kishikawa K; Ito M; Nakamura T
Bone; 2008 Nov; 43(5):840-8. PubMed ID: 18718565
[TBL] [Abstract][Full Text] [Related]
16. [Dynamic effects of glucocorticoid on bone mineral density and microarchitecture: experiment with rats].
Liu SP; Chen J; Yang SM; Wu XP; Liao EY; Sheng ZF; Mo H; Ma YL; Zhang YH; Liu W; Jin Y; Dai RC
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2281-4. PubMed ID: 19087680
[TBL] [Abstract][Full Text] [Related]
17. Supplementation of L-arginine prevents glucocorticoid-induced reduction of bone growth and bone turnover abnormalities in a growing rat model.
Pennisi P; D'Alcamo MA; Leonetti C; Clementi A; Cutuli VM; Riccobene S; Parisi N; Fiore CE
J Bone Miner Metab; 2005; 23(2):134-9. PubMed ID: 15750691
[TBL] [Abstract][Full Text] [Related]
18. Effect of controlled zinc release on bone mineral density from injectable Zn-containing beta-tricalcium phosphate suspension in zinc-deficient diseased rats.
Otsuka M; Ohshita Y; Marunaka S; Matsuda Y; Ito A; Ichinose N; Otsuka K; Higuchi WI
J Biomed Mater Res A; 2004 Jun; 69(3):552-60. PubMed ID: 15127402
[TBL] [Abstract][Full Text] [Related]
19. Effect of dietary-induced metabolic acidosis and ovariectomy on bone mineral density and markers of bone turnover.
Macleay JM; Olson JD; Turner AS
J Bone Miner Metab; 2004; 22(6):561-8. PubMed ID: 15490266
[TBL] [Abstract][Full Text] [Related]
20. Bone disease induced by phenytoin therapy: clinical and experimental study.
Moro-Alvarez MJ; Díaz Curiel M; de la Piedra C; Mariñoso ML; Carrascal MT
Eur Neurol; 2009; 62(4):219-30. PubMed ID: 19628941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
